circ_0007385 served as competing endogenousRNAformiR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells

被引:51
作者
Ye, Yancheng [1 ]
Zhao, Liangcun [1 ]
Li, Qingke [2 ]
Xi, Caixia [3 ]
Li, Yinghong [4 ]
Li, Zhengguo [3 ]
机构
[1] Gansu Wuwei Tumor Hosp, Dept Pharm, Wuwei, Peoples R China
[2] Gansu Wuwei Tumor Hosp, Dept Lab Med, Wuwei, Peoples R China
[3] Gansu Wuwei Tumor Hosp, Dept Resp Med, Wuwei, Peoples R China
[4] Gansu Wuwei Tumor Hosp, Dept Integrated Tradit Chinese & Western Med, Wuwei, Peoples R China
关键词
circ_0007385; HMGB1; miR-519d-3p; NSCLC; CIRCULAR RNA; IN-VITRO; PROLIFERATION; SENSITIVITY; INHIBITION; BIOGENESIS; EXPRESSION; INCREASES; CARCINOMA; GROWTH;
D O I
10.1111/1759-7714.13527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Circular RNAs (circRNAs) have been closely implicated in competing endogenous RNA (ceRNA) network among human cancers including non-small cell lung cancer (NSCLC). However, the role of most circRNAs in NSCLC remains to be determined. Here, we aimed to investigate the role of hsa_circ_0007385 (circ_0007385) in NSCLC cells. Methods Expression of hsa_circ_0007385 (circ_0007385), miRNA (miR)-519d-5p and high-mobility group box 1 (HMGB1) was measured by real-time quantitative PCR and western blotting. Functional experiments were evaluated by cell counting kit (CCK)-8, flow cytometry, fluorescein active caspase-3 staining kit, transwell assays, western blotting, and xenograft experiment. The relationship among circ_0007385,miR-519d-5p and HMGB1 was testified by dual-luciferase reporter assay. Kaplan-Meiersurvival curve identified overall survival in NSCLC patients. Results circ_0007385 expression was higher in NSCLC tissues and cell lines, and was associated with poor overall survival. Silencing circ_0007385 could suppress cell proliferation, migration and invasion in A549 and H1975 cells, as well as cisplatin (DDP) resistance. Moreover, circ_0007385 silence retarded tumor growth of A549 cells in vivo. Molecularly, there was a direct interaction between miR-519d-3p and either circ_0007385 or HMGB1; expression of miR-519d-3p was downregulated in NSCLC tumors in a circ_0007385-correlated manner, and circ_0007385 could indirectly regulate HMGB1 via miR-519d-3p. Functionally, both inhibiting miR-519d-3p and restoring HMGB1 could overturn the suppressive effect of circ_0007385 knockdown on cell proliferation, migration, invasion, and DDP resistance. Conclusions Collectively, circ_0007385 deletion could function anti-tumor role in NSCLC by suppressing malignant behaviors and DDP resistance in vitro and in vivo via circ_0007385/miR-519d-3p/HMGB1 axis. These outcomes might enhance our understanding of the molecular mechanisms underlying the malignant progression of NSCLC. Key pointsSignificant findings of the study circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival. Silenced circ_0007385 suppressed NSCLC cell proliferation, migration, invasion, and DDP resistance in vitro, and tumor growth in vivo. circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival. What this study adds miR-519d-3p could directly interact with circ_0007385 and HMGB1 in NSCLC cells. A promising circ_0007385/miR-519d-3p/HMGB1 regulatory pathway was determined in NSCLC cells.
引用
收藏
页码:2196 / 2208
页数:13
相关论文
共 50 条
[41]   Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway [J].
Niu, Rong ;
Li, Dong ;
Chen, Jian ;
Zhao, Wentao .
CELL CYCLE, 2022, 21 (01) :86-100
[42]   circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway [J].
Sun, Changpeng ;
Guan, Hongjun ;
Li, Jinjin ;
Gu, Yinfeng .
OPEN MEDICINE, 2023, 18 (01)
[43]   Long noncoding RNA ADAMTS9-AS2 is regulated by DNA methyltransferase 1 and inhibits the malignant behaviors of non-small cell lung cancer cells [J].
Xue, Feng ;
Zhu, Lin ;
Liu, Sha ;
Liu, Wei ;
Yang, Chunyu ;
Wang, Liyan ;
Cai, Li .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03) :2599-2608
[44]   Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells [J].
Zhang, Peng-Fei ;
Pei, Xu ;
Li, Ke-Sang ;
Jin, Li-Na ;
Wang, Fei ;
Wu, Jing ;
Zhang, Xue-Mei .
MOLECULAR CANCER, 2019, 18 (01)
[45]   circ-ATAD1 as Competing Endogenous RNA for miR-191-5p Forces Non-small Cell Lung Cancer Progression [J].
Wan, Zhihua ;
Jia, Shanshan ;
Lu, Junhua ;
Ge, Xiangjing ;
Chen, Qinghua .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (08) :5099-5113
[46]   β-elemene enhances cisplatin sensitivity of non-small cell lung cancer cells via the miR-17-5p/STAT3 axis [J].
Tian, Qian ;
Tong, Wenxian ;
He, Anbing .
CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
[47]   CircNFIX Acts as a miR-212-3p Sponge to Enhance the Malignant Progression of Non-Small Cell Lung Cancer by Up-Regulating ADAM10 [J].
Lu, Jun ;
Zhu, Ying ;
Qin, Youfa ;
Chen, Yikai .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :9577-9587
[48]   Circular RNA circLDB2 functions as a competing endogenous RNA to suppress development and promote cisplatin sensitivity in non-squamous non-small cell lung cancer [J].
Wang, Yuanyuan ;
Li, Luguang ;
Zhang, Weiyu ;
Zhang, Guojun .
THORACIC CANCER, 2021, 12 (13) :1959-1972
[49]   USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis [J].
Tao, Rancen ;
Liu, Zuo ;
Zhang, Zhenning ;
Zhang, Zhenfa .
ANTI-CANCER DRUGS, 2024, 35 (06) :483-491
[50]   MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-κB pathway [J].
Jiang, Peng ;
Jia, Wanjun ;
Wei, Xiaoping ;
Zhang, Xiaoxia ;
Wang, Cheng ;
Li, Bin ;
Song, Tieniu ;
Yang, Jianbao ;
Zhu, Duojie ;
Meng, Yuqi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12) :11545-11553